Stage-
Conditions
Interventions
Tissue were stained with immunoglobulin CD147 and interpreted by a blind pathologist
CD147 immunohistochemistry
Sponsors
Prince of Songkla University
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age more than 20 years old Stage IV NSCLC patients by the 7th TNM staging in Songklanakarind Hospital ECOG-PS* 0-2 Participants received platinum-based as first-line chemotherapy. Pathological tissue was sufficient for immunohistochemistry test. Available thoracic imaging for evaluation of chemotherapy response *ECOG-PS= Eastern Cooperative Oncology Group-Performance Status
Exclusion criteria
Exclusion criteria: Patients had other cancer. Patients had secondary lung metastasis from other cancer. Patients received concurrent treatment with surgical resection or radiotherapy. Patients decide best supportive care and denied chemotherapy. No available thoracic imaging for evaluation of chemotherapy response
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platinum-based chemotherapy treatment outcomes Disease progress, death Progression free survivol | — |
Secondary
| Measure | Time frame |
|---|---|
| None | — |
Countries
Thailand
Contacts
Public ContactKatkanit Thammakumpee
Faculty of Medicine, Prince of Songkla University
Outcome results
None listed